High materiality8/10
Spruce Biosciences price target lowered to $104 from $123 at Guggenheim
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim lowers SPRB target to $104; current price $52.64. The target remains roughly double the price, implying strong upside.
- Target $104 vs price $52.64; bullish upside.
Key facts
- 01
Target: $104
- 02
Posted price: $52.64
- 03
Analyst firm: Guggenheim
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.